Applied Imaging joins EU-funded cancer study
This article was originally published in Clinica
Executive Summary
Applied Imaging has become one of three commercial partners accepted as a collaborator on the DISMAL-project, a European-based, three-year biomarker study on detection and dissemination of tumour cells.